AP (Thailand) PCL (BKK:AP)

Intra-Cellular Therapies Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	2,327	2,565	2,041	1,650	2,070	2,740
Cash & Short-Term Investments	2,327	2,565	2,041	1,650	2,070	2,740
Cash Growth	-19.46%	25.69%	23.68%	-20.28%	-24.46%	380.46%
Accounts Receivable	136.79	147.46	85.45	72.72	69.08	48.57
Other Receivables	56.55	45.74	59.71	30.86	-	30.96
Receivables	193.34	193.2	145.16	103.59	69.08	79.53
Inventory	72,742	71,946	72,256	56,887	48,632	46,922
Other Current Assets	253.84	193.35	130.56	247.68	181.84	156.2
Total Current Assets	75,517	74,898	74,572	58,889	50,953	49,897
Property, Plant & Equipment	350.28	380.43	604.57	683.22	781.78	964.04
Long-Term Investments	7,280	7,667	6,702	6,480	6,644	6,462
Goodwill	100.06	100.06	100.06	100.06	100.06	100.06
Other Intangible Assets	17.82	19.99	92.16	144.98	149.3	132.18
Long-Term Deferred Tax Assets	673.95	678.66	704.95	571.69	505.07	423.13
Other Long-Term Assets	1,149	1,149	1,167	1,357	1,276	745.25
Total Assets	85,087	84,893	83,944	68,227	60,409	58,724
Accounts Payable	2,725	1,993	2,426	2,633	2,041	1,582
Accrued Expenses	3,488	4,012	4,111	3,810	3,072	2,780
Short-Term Debt	3,751	4,674	8,037	3,084	1,727	3,113
Current Portion of Long-Term Debt	7,471	6,444	5,262	4,630	4,500	4,600
Current Portion of Leases	113.57	119.24	128.01	126.64	125.76	119.14
Current Income Taxes Payable	427.21	330.13	477.2	345.26	236.41	212.42
Current Unearned Revenue	624.01	387.84	280.32	331.81	328.83	607.49
Other Current Liabilities	-	648.33	607.46	578.35	408.8	242.17
Total Current Liabilities	18,599	18,608	21,329	15,539	12,439	13,256
Long-Term Debt	21,233	21,836	20,784	15,055	14,720	15,221
Long-Term Leases	58.72	68.78	179.78	228.75	303.37	444.87
Other Long-Term Liabilities	388.52	435.27	509.97	336.14	242.61	269.02
Total Liabilities	40,579	41,248	43,206	31,499	27,986	29,461
Common Stock	3,146	3,146	3,146	3,146	3,146	3,146
Additional Paid-In Capital	89.42	89.42	89.42	89.42	89.42	89.42
Retained Earnings	41,293	40,429	37,522	33,512	29,206	26,046
Total Common Equity	44,528	43,664	40,757	36,747	32,442	29,281
Minority Interest	-19.67	-19.63	-19.67	-19.24	-18.27	-18.05
Shareholders' Equity	44,508	43,645	40,737	36,728	32,423	29,263
Total Liabilities & Equity	85,087	84,893	83,944	68,227	60,409	58,724
Total Debt	32,626	33,142	34,392	23,125	21,376	23,498
Net Cash (Debt)	-30,299	-30,577	-32,351	-21,475	-19,306	-20,758
Net Cash Per Share	-9.63	-9.72	-10.28	-6.83	-6.14	-6.60
Filing Date Shares Outstanding	3,146	3,146	3,146	3,146	3,146	3,146
Total Common Shares Outstanding	3,146	3,146	3,146	3,146	3,146	3,146
Working Capital	56,918	56,289	53,243	43,349	38,513	36,641
Book Value Per Share	14.15	13.88	12.96	11.68	10.31	9.31
Tangible Book Value	44,410	43,544	40,565	36,502	32,192	29,049
Tangible Book Value Per Share	14.12	13.84	12.89	11.60	10.23	9.23
Land	-	23.66	21.41	21.41	21.41	21.41
Buildings	-	47.15	47.15	47.15	47.15	47.15
Machinery	-	644.94	688.96	773.56	738.86	703.06

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.